Annual Report 2023

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2023 103 The United Laboratories International Holdings Limited Annual Report 2023 19. GOODWILL RMB’000 COST At 1 January 2022 and 31 December 2022 and 2023 3,031 Goodwill has been allocated to two individual cash-generating units, including one subsidiary which operates in the Bulk medicine segment and one subsidiary which operates in the Finished products segment. The carrying amounts of goodwill at the end of the reporting period allocated to these units are as follows: 2023 2022 RMB’000 RMB’000 Bulk medicine 774 774 Finished products 2,257 2,257 3,031 3,031